(MedPage Today) — Evidence for the treatment of hereditary angioedema (HAE) in younger children is growing, with expanding treatment options.
A pasteurized formulation of purified C1 inhibitor (Berinert) was approved in 2009 for use in patients…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






